Who Owns the Formula a Chinese Manufacturer Develops for You?

Who owns the formula a manufacturer develops for you?

Ownership of a development formula is a contractual term, not a technical one, and whoever is named as owner in the development agreement holds it. No factory's default position applies automatically: the answer is whatever the contract says, which is why it has to be written before sampling starts rather than negotiated after the first sample proves the product works.

That single sentence explains most disputes in this area. Buyers assume ownership follows payment. Factories assume ownership follows authorship. Both assumptions are reasonable, and neither is enforceable unless it was written down. The practical consequence is that a formula is an asset whose value only becomes obvious once the product sells — and by then the terms are fixed and the buyer's position is the weakest it will ever be. A development cycle that costs 3 months of stability testing before a first shipment is a poor place to discover the ownership question was never asked.

Why does formula ownership get decided too late?

Formula ownership gets decided too late because the first conversations are about product, price and timeline, and ownership feels like a legal detail that can wait until the order is real. It cannot, because the period when the buyer has the most leverage is before the formula exists.

Three conversations postpone the decision, and each one feels reasonable at the time:

1. "Let's see if the sample works first." The sample is developed under whatever terms already exist, so a brief sent without a development agreement means the default — usually factory ownership — quietly applies. Samples ship in 3 to 7 days, fast enough that the terms get fixed before anyone revisits them.
2. "We'll sort the paperwork at production stage." By then the buyer has paid for development, approved a sample and fixed a launch date. Walking away is no longer credible.
3. "Exclusivity is a volume conversation." Exclusivity involves volume, but ownership does not. A buyer can own a formula without exclusivity, and can end up with neither if the question was never asked.

Raising it early costs one paragraph in a contract. Raising it late costs a formula you paid to develop and cannot stop someone else from using.

What are the common ownership arrangements?

There are four arrangements in practice, and they differ in who can use the formula and who can stop others from using it. Most disputes come from a buyer assuming one arrangement while the contract describes another.

The second and third rows are where most brands should sit. The first is acceptable for a fast market test, provided the buyer understands that a competitor can buy the same formula for the same price. The fourth sounds collaborative and is usually the hardest to enforce, because "shared" only works when the contract defines what each side may do with it — and in hair care, genuine joint development is rare enough that it is usually a factory-owned formula described in softer language. A catalogue formula might cost nothing to develop; a brief-built formula is a paid development project, and that payment is precisely what makes the ownership question worth settling.

What should a development agreement actually say?

A development agreement is the document that fixes formula ownership, permitted use and exit terms before any sample is made. It should state who owns the formula, what the factory may do with it, how long any exclusivity lasts, and what happens if the relationship ends. Those four points cover nearly every scenario that becomes a dispute, and a project typically runs 3 to 6 months before a first shipment — so a gap gets discovered at the end of that period.

Each point has a failure mode worth recognising before signing:

• Ownership. Name the owner explicitly, tying the clause to a specific document set.
• Permitted use. Say whether the factory may produce the same or a similar formula for anyone else. Silence reads as permission.
• Exclusivity term and scope. Name a duration, a territory and a channel. "Exclusive" without those three cannot be enforced.
• Exit. Say what happens to the formula, batch records and stability data if the buyer moves. An owner without manufacturing instructions owns little.

In our contracts, ownership and exclusivity are written in before development starts.

Why does the exit clause decide whether ownership is worth anything?

Because ownership without documentation is a right with no operational content. A formula sheet lets a new factory match closely, but not identically. A specification without stability data forces repeat testing before shipment. That is typically 3 months for an anhydrous product and 6 months for an emulsion — a delay measured in quarters.

The documents that decide this are specific. They are the formula sheet with percentages, the raw material specification naming each supplier, the batch manufacturing record, stability data and the packaging specification. A buyer holding four of those five can usually transfer production. A buyer holding only the formula sheet has an asset it cannot reproduce anywhere, so the original factory keeps the real leverage regardless of what the contract says about ownership.

In practice, the exit clause belongs beside the ownership clause. Separating them creates a buyer who believes it owns a formula, then discovers at the moment of moving that ownership was never the binding constraint.

How does exclusivity relate to volume?

Exclusivity is normally tied to volume, because a factory that cannot sell a formula to anyone else depends on the buyer to make it worth developing. The link is commercial, not punitive: exclusivity is granted against a commitment, and it usually lapses if the commitment is not met.

That matters before asking for exclusivity, because an unconditional exclusive on a first order is a request most factories will price into the development fee rather than grant outright. A conditional exclusive — named market and channel, reviewed annually against an agreed volume — is easier to obtain and easier to live with. At MOQ levels of 1,000 to 5,000 pieces per SKU, a first order rarely justifies an unconditional exclusive.

Two questions make the conversation concrete: what volume makes the exclusive worth holding for the factory, and what happens in a year where the buyer falls short. The second matters more, because a term with no defined consequence gets renegotiated at the worst possible moment.

What happens to the formula if you change suppliers?

If the buyer owns the formula, changing suppliers should mean transferring documents rather than reformulating. That transfer only works when the agreement names the documents: the formula sheet, the specification, the batch manufacturing record, the stability data and the raw material sources.

Missing any one of them forces a partial rebuild. A formula sheet without the raw material source can be matched closely but not identically. A specification without the stability data means the new factory must repeat testing before it can ship, which is typically a 3-month delay for an anhydrous product and 6 months for an emulsion — the same protocol length that governs a first launch.

The commercial point is that ownership is only as useful as the documents attached to it. An owner who negotiates ownership but not document transfer has bought the right to say they own something, not the ability to make it anywhere else.

What this looks like in practice

At TRESSFIELD, ownership and exclusivity are agreed per project and written into the contract before development starts, not decided after the first sample. Where exclusivity is agreed, the same formula is not manufactured for another client. The formulation work is built to the buyer's brief rather than pulled from a stock list, which is what makes a per-project ownership term meaningful in the first place.

That sequencing is the practical takeaway. The question worth asking a factory is not whether they offer exclusive formulas — most will say yes — but at what point in the process the ownership term gets written down. An answer of "before we start developing" is workable. An answer of "once we see how the sample performs" means the term will be negotiated by the party holding the sample.

If you are commissioning development and want the ownership question settled before money is spent, send the product brief and ask for the development terms in the same reply. The terms are cheaper to agree than to renegotiate.